美国VeroScience研究中心神经生理学研究博士后职位
2014-12-12 14:11 来源: 未知 作者: liuxuehr
VeroScience is a small but very well developed biotechnology company focusing on neuroendocrine therapies for metabolic and immunological diseases. The company developed and owns Cycloset®, an FDA-approved therapy for the treatment of type 2 diabetes. VeroScience also has a strong pipeline of metabolic disease products and therapies for immunological disorders. The company is a hybrid of academic environment mindset and industrial focus within a small and efficient organization. The company conducts preclinical and clinical research nation-wide, utilizing strong academic and pharmaceutical industry collaborations to advance its development programs.
声明：凡本网注明"来源：XXX"的文/图等稿件，本网转载出于传递更多信息及方便产业探讨之目的，并不意味着本站赞同其观点或证实其内容的真实性，文章内容仅供参考。如其他媒体、网站或个人从本网站转载使用，须保留本网站注明的“来源”，并自负版权等法律责任。作者如果不希望被转载或者联系转载等事宜，请与我们联系。
